Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lacosamide in neonatal seizures
NCT04519645Phase 2Terminated
- Sponsor
- UCB
- Start
- Mar 2021
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of lacosamide in neonatal seizures, sponsored by UCB. Started Mar 2021; status: terminated.
02
Drugs
lacosamide
03
Conditions
neonatal seizures
Beyond the preview
Go deeper on NCT04519645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04519645.